Ethan V. Abel

3.1k citations

30 papers · 2.3k indexed · h-index 22

Oncology top 2%
- Cancer Cells and Metastasis 10
- Pancreatic and Hepatic Oncology Research 10
Cancer Research top 5%
Molecular Biology top 5%
- Melanoma and MAPK Pathways 11
- Epigenetics and DNA Methylation 3
- Renal and related cancers 3
- PI3K/AKT/mTOR signaling in cancer 3
Immunology top 10%
Immunology and Allergy top 10%
- Cell Adhesion Molecules Research 5
Pathology and Forensic Medicine
- Cancer Mechanisms and Therapy 2

Co-authors: Andrew E. Aplin Diane M. Simeone Kevin J. Basile Edward Kim Lidong Wang John M. Koomen Keiran S.M. Smalley Jane L. Messina
Cited by: Oncology Cancer Research Molecular Biology
Journals: Cancer Research (6 papers)Genes & Development (3 papers)Oncogene (3 papers)
Partner nations: United States Germany France

In The Last Decade

Ethan V. Abel

29 papers receiving 2.3k citations

Peers

Countries citing papers authored by Ethan V. Abel

Since Specialization

Citations

This map shows the geographic impact of Ethan V. Abel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ethan V. Abel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ethan V. Abel more than expected).

Fields of papers citing papers by Ethan V. Abel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ethan V. Abel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ethan V. Abel. The network helps show where Ethan V. Abel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ethan V. Abel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ethan V. Abel Line = papers co-authored together Ethan V. Abel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma Molecular Cancer ·C. A. Mawson,K. Humphrey,Eduardo Cortes Gomez,Myrddin Gardi.,Vishnu Kumarasamy,道山弘康,Mark D. Long,Michael E. Feigin,Agnieszka K. Witkiewicz,Karen M. Mann,Erik S. Knudsen,Ethan V. Abel	2025	0
2	The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer Cancer Research ·Vishnu Kumarasamy,Myrddin Gardi.,Costakis Frangou,道山弘康,Ahmed Z. El-attar,Veran Nicolas,Prasenjit Dey,Ethan V. Abel,Erik S. Knudsen,Agnieszka K. Witkiewicz	2024	19
3	A surgical orthotopic approach for studying the invasive progression of human bladder cancer Nature Protocols ·Guadalupe Lorenzatti Hiles,C Patterson Ashley,Hong-Xing Gu,Kathleen C. Day,Azizatul Ula,R Nihal,Stuart Rankin Wallace,최현빈,Mayumi Onozawa,Ethan V. Abel,Monica Liebert,Phillip L. Palmbos,Aaron M. Udager,Evan T. Keller,Mark L. Day	2019	24
4	HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties eLife ·Ethan V. Abel,Masashi Goto,Brian Magnuson,JP Dodds,朱传棨,啓子新良,del Rio Carlos,Chandan Kumar‐Sinha,Michele Dziubinski,Sumithra Urs,Lidong Wang,Jiaqi Shi,Meghna Waghray,Mats Ljungman,Howard C. Crawford,Diane M. Simeone	2018	53
5	GM-CSF Mediates Mesenchymal–Epithelial Cross-talk in Pancreatic Cancer Cancer Discovery ·Meghna Waghray,Malica Yalamanchili,Michele Dziubinski,Mina Zeinali,Fan Xiang-dong,Huibin Yang,Multidrug- Reslstant Enterobacteriaceae,Sumithra Urs,Marina Pasca di Magliano,Theodore H. Welling,Phillip L. Palmbos,Ethan V. Abel,Vaibhav Sahai,Sunitha Nagrath,Lidong Wang,Diane M. Simeone	2016	152
6	Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells Oncogene ·Inna V. Fedorenko,Ethan V. Abel,John M. Koomen,Bin Fang,Elizabeth R. Wood,Y. Ann Chen,Kate Fisher,Sushma Iyengar,Kimberly B. Dahlman,Jennifer A. Wargo,Keith T. Flaherty,Jeffrey A. Sosman,Vernon K. Sondak,Jane L. Messina,Geoffrey T. Gibney,Keiran S.M. Smalley	2015	58
7	ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis Genes & Development ·Lidong Wang,Huibin Yang,Ethan V. Abel,Gina M. Ney,Phillip L. Palmbos,Filip Bednar,Yaqing Zhang,吉红,Meghna Waghray,Scott R. Owens,John E. Wilkinson,Jayendra Prasad,Mats Ljungman,Andrew D. Rhim,Marina Pasca di Magliano,Diane M. Simeone	2015	56
8	FOXD3 Modulates Migration through Direct Transcriptional Repression of TWIST1 in Melanoma Molecular Cancer Research ·Michele B. Weiss,Ethan V. Abel,Wasitohadi Wasitohadi,Andrew E. Aplin	2014	23
9	Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma Clinical Cancer Research ·Edward Kim,Vaibhav Sahai,Ethan V. Abel,Kent A. Griffith,Joel K. Greenson,Naoko Takebe,Gazala Khan,John Blau,Ronald A. Craig,Ulysses J. Balis,Mark M. Zalupski,Diane M. Simeone	2014	236
10	The Notch Pathway Is Important in Maintaining the Cancer Stem Cell Population in Pancreatic Cancer PLoS ONE ·Ethan V. Abel,Edward Kim,Jingjiang Wu,Mark J. Hynes,Filip Bednar,Erica Proctor,Lidong Wang,Michele Dziubinski,Diane M. Simeone	2014	129
11	In Vivo MAPK Reporting Reveals the Heterogeneity in Tumoral Selection of Resistance to RAF Inhibitors Cancer Research ·Kevin J. Basile,Ethan V. Abel,Wasitohadi Wasitohadi,Edward J. Hartsough,Paolo Fortina,Andrew E. Aplin	2013	30
12	Biology and Clinical Applications of Pancreatic Cancer Stem Cells Gastroenterology ·Ethan V. Abel,Diane M. Simeone	2013	87
13	SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells Oncogenesis ·Marta Herreros‐Villanueva,Zhang Js,Alexander Köenig,Ethan V. Abel,Thomas C. Smyrk,William R. Bamlet,正雄豊田,Timothy S. Gomez,Diane M. Simeone,Luís Bujanda,Daniel D. Billadeau	2013	264
14	TWIST1 Is an ERK1/2 Effector That Promotes Invasion and Regulates MMP-1 Expression in Human Melanoma Cells Cancer Research ·Michele B. Weiss,Ethan V. Abel,Naila,Kevin J. Basile,Adam C. Berger,Andrew E. Aplin	2012	124
15	GSK3β Inhibition Blocks Melanoma Cell/Host Interactions by Downregulating N-Cadherin Expression and Decreasing FAK Phosphorylation Journal of Investigative Dermatology ·Victor Navarro Ríos,Kim H.T. Paraiso,Vito W. Rebecca,Liliana Cantini,Ethan V. Abel,Nicholas Pagano,Eric Meggers,Rahel Mathew,Clemens Krepler,Victoria Izumi,Bin Fang,John M. Koomen,Jane L. Messina,Meenhard Herlyn,Keiran S.M. Smalley	2012	30
16	PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression Cancer Research ·Kim H.T. Paraiso,Yun Xiang,Vito W. Rebecca,Ethan V. Abel,Y. Ann Chen,Noémi Saly,Elizabeth R. Wood,Inna V. Fedorenko,Vernon K. Sondak,Alexander R.A. Anderson,Antoni Ribas,Maurizia Dalla Palma,Katherine L. Nathanson,John M. Koomen,Jane L. Messina,Keiran S.M. Smalley	2011	406
17	Adaptive upregulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells Oncogene ·Kevin J. Basile,Ethan V. Abel,Andrew E. Aplin	2011	52
18	FOXD3 Is a Mutant B-RAF–Regulated Inhibitor of G1-S Progression in Melanoma Cells Cancer Research ·Ethan V. Abel,Andrew E. Aplin	2010	69
19	Mcl-1 Is Required for Melanoma Cell Resistance to Anoikis Molecular Cancer Research ·Suyama Minoru,Whitney Longmate,Ethan V. Abel,Andrew E. Aplin	2009	108
20	Cyclin D3 Expression in Melanoma Cells Is Regulated by Adhesion-dependent Phosphatidylinositol 3-Kinase Signaling and Contributes to G1-S Progression Journal of Biological Chemistry ·Miquel Àngel Salvà Cantarellas,Ethan V. Abel,Suyama Minoru,Andrew E. Aplin	2006	34

About Ethan V. Abel

Ethan V. Abel is a scholar working on Immunology and Allergy, Oncology, Molecular Biology, Immunology and Cancer Research, having authored 30 papers that have together received 2.3k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (11 papers), Cancer Cells and Metastasis (10 papers), Pancreatic and Hepatic Oncology Research (10 papers), Cell Adhesion Molecules Research (5 papers), Epigenetics and DNA Methylation (3 papers), Renal and related cancers (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (430 citations), Molecular Biology (1.7k citations), Immunology (329 citations) and Immunology and Allergy (83 citations). Ethan V. Abel has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Andrew E. Aplin, Diane M. Simeone, Kevin J. Basile, Edward Kim, Lidong Wang, John M. Koomen, Keiran S.M. Smalley, Jane L. Messina, Inna V. Fedorenko and Vernon K. Sondak. Their work appears in journals such as Cancer Research, Genes & Development, Oncogene, Molecular Cancer Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact